COMMUNIQUÉS West-GlobeNewswire

Fear of Rejection is Transplant Patient’s Top Concern
21/08/2019
CareDx partnership with American Association of Kidney Patients yields key patient insights BRISBANE, Calif., Aug. 21, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused [...]
BioCardia Reports 2019 Second Quarter Financial Results and Business Highlights
21/08/2019
SAN CARLOS, Calif., Aug. 21, 2019 (GLOBE NEWSWIRE) -- BioCardia ® , Inc. [Nasdaq: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today reported financial results [...]
HempAmericana Launches North American CBD Sales Force Following Successful Inventory Build
21/08/2019
NEW YORK, Aug. 21, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE – HempAmericana, Inc. (OTC: HMPQ) (“HempAmericana” or the “Company”), an emerging leader in the CBD products market, is very excited to announce the launch of [...]
CURE Pharmaceutical [OTCQB: CURR] Takes First Step To Secure Hemp CBD Supply Chain by Partnering with Fytiko Farms
21/08/2019
OXNARD, Calif., Aug. 21, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced it has signed a deal with Oklahoma-based hemp grower Fytiko Farms. [...]
Altimmune Announces $3.7 Million in Additional BARDA Funding to Advance NasoShield™ Clinical Development
21/08/2019
Phase 1b clinical trial will study effect of dosing methodology on immune response to intranasal anthrax vaccine GAITHERSBURG, Md., Aug. 21, 2019 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage [...]
Cara Therapeutics Enters into Commercial License Agreement with Enteris BioPharma, Inc. for Peptelligence® Oral Formulation Technology
21/08/2019
Peptelligence® technology currently used in Oral KORSUVA™ formulation STAMFORD, Conn., Aug. 21, 2019 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and [...]
Pluristem Therapeutics to Host Key Opinion Leader Call on its Acute Radiation Syndrome and Hematological Deficiencies Programs
21/08/2019
HAIFA, Israel, Aug. 21, 2019 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading regenerative medicine company developing novel placenta-based cell therapy products, today announced that [...]
YSS Corp. Announces Second Quarter 2019 Results and Operational Update
21/08/2019
CALGARY, Alberta, Aug. 21, 2019 (GLOBE NEWSWIRE) -- YSS Corp.™ (the “ Company ” or “ YSS ”) (TSXV: YSS) (WKN: A2PMAX) is pleased to announce the financial results for the three and six months ended June 30, 2019 and [...]
Tonix Pharmaceuticals and Massachusetts General Hospital Enter into Research Collaboration to Develop Tonix’s Third Generation Anti-CD154 Monoclonal Antibody, TNX-1500, for the Treatment and Prevention of Organ Transplant Rejection
21/08/2019
NEW YORK, Aug. 21, 2019 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced the signing of a research collaboration [...]
RedHill Biopharma Announces Acceptance of Oral Presentations on RHB-105 (H. pylori) and RHB-104 (Crohn’s Disease) Phase 3 Data at ACG 2019 Annual Scientific Meeting
21/08/2019
TEL-AVIV, Israel and RALEIGH, N.C., Aug. 21, 2019 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq: RDHL ) (Tel-Aviv Stock Exchange: RDHL ) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]
Sharps Compliance Reports Fiscal 2019 Fourth Quarter Results
21/08/2019
Fourth quarter 2019 revenue of $12.2 million, an increase of 23% over prior year Record fourth quarter customer billings of $12.7 million, an increase of 31% over prior year Gross margin improved to 32% Net income of $0 [...]
Teleflex to Present at the Wells Fargo Securities 2019 Healthcare Conference
21/08/2019
WAYNE, Pa., Aug. 21, 2019 (GLOBE NEWSWIRE) -- Liam Kelly, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Wells Fargo Securities 2019 Healthcare Conference at the Westin Copley Place [...]
Cerecor Receives Fast Track Designation from FDA for CERC-802 for the Treatment of Mannose-Phosphate Isomerase Deficiency
21/08/2019
ROCKVILLE, Md., Aug. 21, 2019 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare and orphan diseases in [...]
Tetra Bio-Pharma Announces Joint Venture with Thorne and Onegevity Health to Form CB2 Therapeutics
21/08/2019
Joint Venture to Develop Therapeutics Targeting Chronic Inflammatory Conditions OTTAWA, Aug. 21, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc., (TSX-V: TBP) (OTCQB: TBPMF), a leader in drug discovery and development [...]
Orphazyme Interim Report First Half 2019 Presentation
21/08/2019
Investor news Orphazyme A/S Company Registration No. 32266355 Copenhagen, Denmark, August 21, 2019 – Orphazyme A/S (ticker: ORPHA.CO), a biopharmaceutical company dedicated to developing treatments for patients living [...]
Amarin to Participate in a Fireside Chat at Citi’s 14th Annual Biotech Conference
21/08/2019
BEDMINSTER, N.J. and DUBLIN, Ireland, Aug. 21, 2019 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a pharmaceutical company focused on the commercialization and development of therapeutics to improve [...]
Donnelly Group Launches Wholesale Cannabis Distribution Venture, Goodtrip Supply
21/08/2019
Launch signals expanded investment in cannabis industry, granting Hobo Recreational Cannabis Store exclusive access to cannabis accessories not currently available in Canada VANCOUVER, British Columbia, Aug. 21, 2019 ( [...]
Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – June 30, 2019
21/08/2019
Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – June 30, 2019 Message from the CEO On July 4 we were able to announce that the first patient had been recruited and dosed in the company’ [...]
AroCell AB (publ) Interim Report January 1st to June 30th 2019
21/08/2019
Word from the CEO “It is with pleasure that I can say that the second quarter of 2019 became one of the most exciting and active quarters in AroCell's history. The goal of establishing AroCell as the given partner and [...]

Pages